Screening Trial of Nivolumab With Image Guided, Stereotactic Body Radiotherapy (SBRT) Versus Nivolumab Alone in Patients With Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

Condition:   Head and Neck Squamous Cell Carcinoma (HNSCC)
Interventions:   Drug: Nivolumab;   Radiation: Stereotactic Body Radiation Therapy (SBRT)
Sponsors:   Memorial Sloan Kettering Cancer Center;   University of Chicago
Recruiting - verified February 2016

from #ORL via xlomafota13 on Inoreader http://ift.tt/1WryarN
via IFTTT